Literature DB >> 35020115

User Perspectives on Professional Support and Service Use During Psychiatric Medication Discontinuation.

Sabrina Darrow1, Morgan Pelot2, Sarah Naeger3, Laysha Ostrow2.   

Abstract

Psychiatric medication discontinuation is common and can have negative impacts. Until recently, most research on discontinuation happened in an adherence/compliance framework. There is now recognition that discontinuation may be a desired goal for many individuals. The purpose of the present paper is to describe the results of a pioneering survey to explore professional support to service users during medication discontinuation to inform clinical practice and guide future research. Survey responses from 250 service users were summarized with regard to their use of prescriber and psychotherapy services during the process of discontinuing psychiatric medication. Only 65% of respondents reported seeing a prescriber and less than 50% reported seeing a psychotherapist while attempting to discontinue psychiatric medication. Combined with respondents' answers describing the decision-making process and support received from these services, this paper identifies gaps in service and the need to improve providers' ability to support individuals while they discontinue psychiatric medication.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Discontinuation; Provider relationships; Psychiatric medication; Service user perspectives

Mesh:

Year:  2022        PMID: 35020115     DOI: 10.1007/s10597-021-00933-3

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  16 in total

1.  Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.

Authors:  Guy Chouinard; Virginie-Anne Chouinard
Journal:  Psychother Psychosom       Date:  2008-01-25       Impact factor: 17.659

2.  Discontinuing Psychiatric Medications: A Survey of Long-Term Users.

Authors:  Laysha Ostrow; Lauren Jessell; Manton Hurd; Sabrina M Darrow; David Cohen
Journal:  Psychiatr Serv       Date:  2017-07-17       Impact factor: 3.084

3.  Noncompliance, Nonadherence, and Dropout: Outmoded Terms for Modern Recovery-Oriented Mental Health.

Authors:  David Roe; Larry Davidson
Journal:  Psychiatr Serv       Date:  2017-07-03       Impact factor: 3.084

4.  Adverse Effects of Antidepressants Reported by a Large International Cohort: Emotional Blunting, Suicidality, and Withdrawal Effects.

Authors:  John Read; James Williams
Journal:  Curr Drug Saf       Date:  2018

5.  Retrospective Accounts of the Process of Using and Discontinuing Psychiatric Medication.

Authors:  Shimon Katz; Hadass Goldblatt; Ilanit Hasson-Ohayon; David Roe
Journal:  Qual Health Res       Date:  2018-08-22

6.  How many of 1829 antidepressant users report withdrawal effects or addiction?

Authors:  John Read; Claire Cartwright; Kerry Gibson
Journal:  Int J Ment Health Nurs       Date:  2018-06-05       Impact factor: 3.503

7.  The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample.

Authors:  Nicola Morant; Kiran Azam; Sonia Johnson; Joanna Moncrieff
Journal:  J Ment Health       Date:  2017-08-31

8.  Understanding how clinician-patient relationships and relational continuity of care affect recovery from serious mental illness: STARS study results.

Authors:  Carla A Green; Michael R Polen; Shannon L Janoff; David K Castleton; Jennifer P Wisdom; Nancy Vuckovic; Nancy A Perrin; Robert I Paulson; Stuart L Oken
Journal:  Psychiatr Rehabil J       Date:  2008

Review 9.  Strategies to improve medication adherence in patients with schizophrenia: the role of support services.

Authors:  Peggy El-Mallakh; Jan Findlay
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-16       Impact factor: 2.570

10.  'In my life antidepressants have been…': a qualitative analysis of users' diverse experiences with antidepressants.

Authors:  Kerry Gibson; Claire Cartwright; John Read
Journal:  BMC Psychiatry       Date:  2016-05-11       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.